Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
154.59
-4.65 (-2.92%)
At close: Mar 20, 2026, 4:00 PM EDT
154.59
0.00 (0.00%)
After-hours: Mar 20, 2026, 4:11 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.08 billion as of March 20, 2026. Its market cap has increased by 216.46% in one year.
Market Cap
6.08B
Enterprise Value
5.81B
1-Year Change
216.46%
Ranking
Category
Stock Price
$154.59
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.08B, an increase of 4,106.60%. That is a compound annual growth rate of 161.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 6.26B | 4.39% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 7.47B |
| Arcellx | 6.69B |
| Kymera Therapeutics | 6.50B |
| Protagonist Therapeutics | 6.49B |
| Rhythm Pharmaceuticals | 6.17B |
| Cogent Biosciences | 5.62B |
| CG Oncology | 5.56B |
| PTC Therapeutics | 5.55B |